Kano Therapeutics is a biotech company that focuses on targeted correction of gene-length stretches of DNA through a new class of biomaterial: circular single-stranded DNA. The company develops genetic payloads for genetic cures.

Kano Therapeutics

Kano Therapeutics is a founder-led biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them, empowering scientists, labs, and companies with the building blocks they need to cross the chasm to cures.

Explore our newest roles and join a team that's at the forefront of scientific innovation:
🌟 Senior Scientist, Downstream Process Development & Analytics
      🔗 Apply Now: https://lnkd.in/eBusJGPB
🌟 Sr. Research Associate/Scientist, Mammalian Cell Genome Editing
      🔗 Apply Now: https://lnkd.in/ecJrDsZE

Discover more about our career opportunities and how you can make an impact: 🔗 https://lnkd.in/e7fVWf2e

We're hiring! Kano is seeking a discovery research scientist to help bring our early pipeline programs closer to patients. 

If you're interested in joining our team apply here: https://lnkd.in/dSK-YXiQ

Kano seeks a hands-on discovery research leader to play a critical role in the development of our preclinical research function. 

You want to manage internal discovery and validation R&D projects and lead Kano’s internal and external program-specific research activities, including validating and de-risking lead candidates?

Apply here: https://lnkd.in/detAbT-x

We are thrilled to announce that we’ve been selected as a spoke of the Advanced Research Projects Agency for Health (ARPA-H) Investor Catalyst Hub network! We are excited to contribute to the community.

Bright Minds: Kano Therapeutics' CEO Floris Engelhardt discusses circular single-stranded DNA, and life as a startup.

She describes how her startup Kano is trying to use circular single-stranded DNA to correct gene length stretches of the genome.

Full video: https://lnkd.in/gguC8Her

COM:KANOTHERAPEUTICS

Kano Therapeutics

Analysis Not Available